These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14968124)
1. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Cataldo DD; Gueders M; Munaut C; Rocks N; Bartsch P; Foidart JM; Noël A; Louis R Lab Invest; 2004 Apr; 84(4):418-24. PubMed ID: 14968124 [TBL] [Abstract][Full Text] [Related]
2. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]. Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602 [TBL] [Abstract][Full Text] [Related]
3. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221 [TBL] [Abstract][Full Text] [Related]
5. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
6. Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma. Liu CJ; Huang YL; Ju JP; Lu CL; Chiu AW J Glaucoma; 2004 Dec; 13(6):486-91. PubMed ID: 15534474 [TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
8. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma. Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912 [TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Young KA; Hennebold JD; Stouffer RL Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461 [TBL] [Abstract][Full Text] [Related]
10. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290 [TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [TBL] [Abstract][Full Text] [Related]
12. [Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats]. Qiao HM; Lu JR; Cheng HJ; Liu L; Ma QS; Fu WY; Zhao FX Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):591-4. PubMed ID: 16191269 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106 [TBL] [Abstract][Full Text] [Related]
14. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse. Wang X; Li Y; Chen J; Guo X; Guan H; Li C Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related]
17. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows. Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587 [TBL] [Abstract][Full Text] [Related]
18. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer. Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648 [TBL] [Abstract][Full Text] [Related]
19. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Galboiz Y; Shapiro S; Lahat N; Rawashdeh H; Miller A Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]